Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 USD | 0.00% | +23.08% | +111.76% |
04-18 | Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine | MT |
04-18 | Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+111.76% | 13.54M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- IMNN Stock
- News Imunon, Inc.
- Celsion : Shares Soar Pre-Bell as FDA Grants Fast-Track Status to Gen-1 to Treat Ovarian Cancer